Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
Baek SY, Noh WC, Ahn SH, Kim HA, Ryu JM, Kim SI, Lee EG, Im SA, Jung Y, Park MH, Park KH, Kang SH, Jeong J, Park E, Kim SY, Lee MH, Kim LS, Lim W, Kim S, Kim HJ.
Baek SY, et al. Among authors: park kh, park e, park mh.
J Clin Oncol. 2023 Nov 1;41(31):4864-4871. doi: 10.1200/JCO.23.00557. Epub 2023 Aug 22.
J Clin Oncol. 2023.
PMID: 37607321
Clinical Trial.